Built to Withstand Trump-Era Attacks on Mifepristone: New Telehealth Provider Serves All 50 States for Sliding-Scale Fee

Telehealth provider At Home Abortion just opened Aug. 11, but the six doctors and nurses running the service have over 100 years combined experience providing abortion and other reproductive healthcare.

At Home Abortion (AHA) is the latest to join the growing field of telehealth abortion providers. AHA is unique in that the company serves patients in all 50 states, offers comprehensive support to all their patients and is based in Europe so is resistant to Trump administration attacks on telehealth abortion with mifepristone. In other words, AHA will be able to continue to provide gold-standard abortion pill service with mifepristone and misoprostol, no matter what the Trump administration, courts or Republican states do to try to suppress mifepristone access inside the United States.

“We’re here to make it as easy, safe and available as possible for people to get care, and we want to support people all the way through,” said an AHA representative.

The intake form takes about five minutes to complete. Clinicians review intake forms within one to 12 hours. When a patient is eligible for a medication abortion, AHA providers send a prescription to a pharmacy in a shield law state that sends FDA-approved medicines—one mifepristone and 12 misoprostol—to the patient in a plain package to any address in the United States plus military bases and US territories. The pill containers do not have the patient’s or the provider’s names on them, ensuring confidentiality. AHA also sends anti-nausea medication. Patients receive the medications in two to four days.

Then, through a secure messaging portal, AHA sends the patient clear and detailed instructions on how to use the medications and what to expect during and after the abortion. AHA also shares a telephone number for the patient to call or text for questions.

AHA providers are available 24/7 to support their patients by voice or text before, during and after the abortion.

“That is really important to us, especially in the United States where people are so afraid of what is going on and afraid to search out other care,” said an AHA representative. “We want to make sure that we are there for them. We know that anxiety increases people’s pain. It makes the experience more difficult. So they need that support.”

In addition to abortion pills, AHA offers miscarriage care, emergency contraception and birth control, as well as abortion pills in advance of pregnancy.

If the Louisiana lawsuit attempting to restrict mifepristone succeeds, or the FDA reinstates medically unnecessary restrictions on mifepristone, AHA has several options to continue providing telehealth abortion with mifepristone to patients in all 50 states and territories.

A Groundbreaking U.N. Resolution Calls Forced Pregnancy What It Is: Reproductive Violence

It took until July 7, 2026, for the world’s leading human rights body to call forcing someone to be pregnant—or forcing them not to be—what it is: reproductive violence. In a landmark resolution adopted unanimously, the U.N. Human Rights Council formally recognized “reproductive violence” as a specific, systemic form of gender-based violence. 

This historic U.N. declaration has implications for the United States, where 41 states ban abortion at some point during pregnancy. These bans block medical providers from offering needed care, and enable police and state attorneys to arrest and criminally prosecute pregnant women whose reproductive decision-making they oppose.

Any law or government action that requires a person to carry a pregnancy to term against their will is a form of bodily assault. The dynamics mirror domestic violence and sexual assault. The core of rape is the violation of consent—taking control of another person’s body and forcing them to submit. Abortion bans likewise hijack a person’s body, stripping them of their bodily integrity and self-determination.

As anti-violence advocate Irene Weiser once asked: “How can we ever begin to end violence against women if the laws of our society will not even guarantee the most fundamental of human right to women—to say at all times, under all circumstances, what we allow to happen to our bodies?”

The Biggest Threat to Women’s Sports Isn’t Trans Athletes. It’s the Trump Administration’s Failure to Uphold Title IX’s Promise of Equal Opportunity.

The politicians who have spent years claiming to “protect women’s sports” have been remarkably absent when it comes to enforcing the law that actually guarantees women equal athletic opportunities. W

hile the Trump administration has devoted enormous energy to policing transgender participation, Title IX complaints involving unequal opportunities, funding and treatment have languished. The result is a political performance that invokes women athletes while doing little to address the inequities they continue to face.

The real defenders of women’s sports are the athletes themselves.

This month alone, women at Christopher Newport University and California Lutheran University successfully used Title IX to force their schools to reverse decisions that eliminated athletic opportunities for women. Their victories are a reminder of what Title IX was designed to do: expand opportunity, not fuel culture wars.

If we truly care about women’s sports, we should celebrate the athletes and advocates who are making the law’s promise of equality a reality—not those who merely claim to speak in their name.

What to Know About Later Abortions: Myths, Barriers and Patient Stories

Later abortion is one of the most stigmatized and least understood aspects of reproductive health, and yet some of the voices perpetuating that stigma come from inside the reproductive rights movement itself. Meanwhile, while most abortions happen in the first trimester, later abortions are increasing as restrictions and bans are delaying care and creating the very conditions that make them necessary.

To address these misconceptions, Erika Christensen and Garin Marschall created Patient Forward after Christensen experienced a later abortion in 2016. The organization is dedicated to eliminating later abortion stigma and barriers.

“We have a lot of folks in the media, including repro[ductive rights] advocates, saying, ‘Nobody wants to do this,’ or, ‘It’s not even available,’ or, ‘Nobody’s getting abortions that late.’ Yes, they are. They’re getting them in safe, modern, incredibly compassionate abortion clinics,” said Christensen. “We do a lot of destigmatizing work.”

Patient Forward emphasizes that most people who obtain a later abortion would have preferred to access an abortion earlier: “Contrary to popular rhetoric, patients do not wait. Rather, they are delayed.”

“We have found that young people are much later to recognize they’re pregnant because their periods are irregular anyway, because they may not be familiar with all the symptoms of pregnancy,” says Dr. Diana Foster Greene of University of California San Francisco. “People with chronic health conditions are also later to discover they’re pregnant because often chronic health conditions have the same symptoms of pregnancy.”

Abortion Rates Continue to Climb as Telehealth Reshapes Post-Dobbs America

Four years after Dobbs, a striking reality has emerged: Abortion bans have not eliminated the need for abortion.

Instead, new #WeCount data show that abortions have increased nationwide, driven in large part by the rapid expansion of telehealth and abortion pills by mail.

Even in states that have attempted to ban abortion entirely, patients continue to find ways to obtain care through shield-law providers, telehealth services and community-based networks.

The data also reveal how dramatically abortion care has changed. Telehealth now accounts for more than a quarter of all abortions provided within the formal healthcare system, offering many patients a safer, more affordable and more private alternative to in-person care.

For people living under bans and severe restrictions, it has become an essential lifeline—one that has reshaped where and how abortion care is delivered across the country.

Yet the numbers likely tell only part of the story. As antiabortion politicians and the Trump administration target mifepristone and telehealth abortion, providers are already adapting.

The lesson of the post-Dobbs era is clear: The demand for abortion has not disappeared, and despite relentless efforts to restrict it, people continue to find ways to access the care they need.

Latin American Feminists Train U.S.-Based Doulas on New Mifepristone Protocol for Second-Trimester Abortions

As Republicans create ever higher barriers to abortion that push abortion seekers later into pregnancy, U.S.-based activists are learning from Latin American feminists who have developed protocols to make second-trimester medication abortion easier and safe: using a double-dose mifepristone protocol for pregnancies 17 weeks of gestation and longer.

For second-trimester abortions, taking two mifepristone means needing less misoprostol, which eases painful contractions and shortens the time to uterine expulsion.

Whereas mifepristone’s side effects are mild—mainly headaches and some nausea that can be treated with medications—misoprostol causes diarrhea, chills and vomiting, which are much harder to experience. Using two mifepristone also significantly reduces the period of painful contractions—from 15 to 18 hours, to often less than six hours, which is critical for women who have to work or care for children or relatives.

Supported women have expressed great satisfaction with the process.

People seek abortion care later in pregnancy for the same reasons they do early in pregnancy, said Erika Christensen, cofounder of Patient Forward, which works to eliminate barriers to abortion care later in pregnancy and provides resources on how find later abortion care—but many are not able to access care as soon as they would like. “This could be because they learned a piece of new information later in their pregnancy, like a health threat to themselves or to the fetus, a new extenuating life circumstance, or it could be the new information could be that they’re pregnant.”

Your Tax Dollars Are Funding the Trump Administration’s Patriarchal Family Agenda

“One in three Americans are under-babied,” declared Trump’s Medicare and Medicaid chief Dr. Mehmet Oz last week, echoing JD Vance’s contempt for “childless cat ladies.”

Guided by evangelical supporters, the Trump administration is eroding longstanding civil rights protections, restricting access to contraception and abortion, and weakening support systems for single mothers and their children. The goal is clear: to pressure women into marriage and motherhood while making the patriarchal family the center of American life.

The administration’s policies closely track the Heritage Foundation’s Project 2025 agenda, which seeks to incentivize what it calls “natural marriage”—a heterosexual household with a breadwinner father, stay-at-home mother and biologically related children.

Meanwhile, the administration’s new Moms.Gov website directs pregnant women to antiabortion organizations that that have been widely criticized for their misleading information about options and for their collection of patients’ sensitive personal information.

Taxpayer dollars are increasingly being used to advance a vision of society rooted in patriarchal family structures and reproductive coercion.

The Supreme Court Preserved Mail-Order Abortion Pills—for Now. Julie Kay Says Providers Are Still Preparing.

Thursday, May 14, at 5 p.m. ET, the Supreme Court’s temporary stay in the mifepristone case is set to expire, once again leaving abortion providers, patients and advocates waiting to see whether the Court will extend the pause, or allow the Fifth Circuit’s restrictions on mifepristone to take effect.

If the Court does nothing, the lower-court ruling could snap back into place, threatening mail-order and telemedicine access to mifepristone, one of the two drugs commonly used in medication abortion.

But abortion rights advocates say the story does not end there. Telemedicine abortion networks, shield-law protections, advance provision and community-based access have already reshaped abortion care in the post-Dobbs landscape—and those systems are continuing to evolve.

Julie F. Kay, a human rights lawyer and founder and executive director of Reproductive Futures, has spent years working at the intersection of reproductive rights, telemedicine abortion and shield-law protections. She co-founded the Abortion Coalition for Telemedicine, challenged Ireland’s abortion ban before the European Court of Human Rights, and co-authored Controlling Women: What We Must Do Now to Save Reproductive Freedom.

Yes, You Can Still Get Abortion Pills by Mail—Here’s What to Know

On May 1, the Fifth Circuit Court of Appeals issued a sweeping ruling seeking to prohibit telehealth prescribing of mifepristone, forcing women to see a provider in-person to acquire the first pill in the standard two-drug medication abortion regimen. The decision would have blocked U.S. clinicians from mailing abortion pills after telehealth consultations nationwide.

On May 4, however, the U.S. Supreme Court temporarily paused that ruling, preserving current telehealth and mail access while the justices consider next steps. The Court’s temporary ruling was set to last until 5 p.m. ET on Monday, May 11, giving the justices time to decide whether to extend the pause or let the lower-court ruling take effect.

Then, on Monday afternoon, the U.S. Supreme Court briefly extended its temporary order preserving telehealth and mail access to mifepristone while the justices continue deliberating over the emergency appeal. Justice Samuel Alito extended the Court’s administrative stay through Thursday, May 14, at 5 p.m. ET, keeping on hold the Fifth Circuit’s May 1 ruling that would have required patients nationwide to obtain the medication through in-person visits. The order means that, for now, people can still access mifepristone through telehealth consultations and mail delivery under the current FDA rules.

National Institute for Reproductive Health president Christian LoBue said the Supreme Court’s decision “preserves telehealth access to mifepristone for now,” but warned it also “prolongs an untenable state of uncertainty for patients and providers nationwide.” Antiabortion forces are “focused on creating chaos and fear, not improving health outcomes,” she said, urging states to instead focus on strengthening protections for providers, patient privacy and access to medication abortion.

Regardless of what the courts ultimately decide, abortion access advocates, international telehealth providers and community networks say they are prepared to continue helping people access abortion pills.

Either way, the infrastructure for medication abortion access already exists—and it is not disappearing.

Trump Administration Launches a Legally Bogus Investigation into Smith College

The Trump administration claims its investigation into Smith College is about defending women. In reality, it is an attack on the rights of women at Smith to define their own community, values and mission without political interference from Washington.

The Department of Education argues that by admitting transgender women and allowing them access to campus housing and facilities, Smith may have violated Title IX. But that argument collapses under even a basic reading of the law. Title IX simply does not apply to admissions at private undergraduate colleges like Smith.

The administration’s complaint is also striking because it is not based on evidence that Smith students have been harmed or excluded from campus life. There is no public record of students filing complaints about the college’s housing, bathrooms or locker rooms policies. Instead, this investigation grew out of pressure from a conservative advocacy group determined to use federal power to impose its ideological agenda on colleges and universities.

Smith’s campus policies were shaped over years by students, faculty and administrators themselves—including cisgender women students who pushed the college to open admissions to transgender women more than a decade ago.

At its core, this investigation is about far more than one women’s college. It reflects the Trump administration’s broader campaign against trans rights, higher education and liberal arts institutions that encourage critical thought, inclusion and intellectual independence.

Congress passed Title IX to expand educational opportunities for women. Now, the administration is attempting to weaponize that same civil rights law to undermine women’s education and bully colleges into abandoning their own principles.